1 Graf, BA, Milbury, PE & Blumberg, JB (2005) Flavonols, flavones, flavanones, and human health: epidemiological evidence. J Med Food 8, 281–290.
2 Arts, ICW & Hollman, PCH (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81, Suppl. 1, S317–S325.
3 Fisher, NDL, Hughes, M, Gerhard-Herman, M & Hollenberg, NK (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21, 2281–2286.
4 Heiss, C, Dejam, A, Kleinbongard, P, Schewe, T, Sies, H & Kelm, M (2003) Vascular effects of cocoa rich in flavan-3-ols. J Am Med Assoc 290, 1030–1031.
5 Taubert, D, Berkels, R, Roesen, R & Klaus, W (2003) Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. J Am Med Assoc 290, 1029–1030.
6 Kuhnle, G, Spencer, JPE, Schroeter, H, Shenoy, B, Debnam, ES, Srai, SK, Rice-Evans, C & Hahn, U (2000) Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem Biophys Res Commun 277, 507–512.
7 Spencer, JPE (2003) Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr 133, S3255–S3261.
8 Gibson, GR, Beatty, ER, Wang, X & Cummings, JH (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.
9 Onoue, M, Kado, S, Sakaitani, Y, Uchida, K & Morotomi, M (1997) Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats. Cancer Lett 113, 179–186.
10 Rastall, RA (2004) Bacteria in the gut: friends and foes and how to alter the balance. J Nutr 134, S2022–S2026.
11 O'Mahony, L, McCarthy, J, Kelly, P, et al. (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128, 541–551.
12 Saggioro, A (2004) Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 38, Suppl. 6, S104–S106.
13 Marteau, PR (2002) Probiotics in clinical conditions. Clin Rev Allergy Immun 22, 255–273.
14 Gibson, GR, Probert, HM, Van Loo, J, Rastall, RA & Roberfroid, MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259–275.
15 Gibson, GR & Fuller, R (2000) Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 130, S391–S395.
16 Kleessen, B, Hartmann, L & Blaut, M (2001) Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr 86, 291–300.
17 Wijnands, MVW, Appel, MJ, Hollanders, VMH & Woutersen, RA (1999) A comparison of the effect of dietary cellulose and fermentable galacto-oligosaccharides, in a rat model of colorectal carcinogenesis: fermentable fibre confers greater protection than non-fermetable fibre in both high and low fat backgrounds. Carcinogenesis 20, 651–656.
18 Gibson, GR, Beatty, ER, Wang, X & Cummings, JH (1995) Selective stimulation of Bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.
19 Clavel, T, Fallani, M, Lepage, P, et al. (2005) Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J Nutr 135, 2786–2792.
20 Deprez, S, Brezillon, C, Rabot, S, Philippe, C, Mila, C, Lapierre, C & Scalbert, A (2000) Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J Nutr 130, 2733–2738.
21 Li, C, Lee, MJ, Sheng, S, et al. (2000) Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol 13, 177–184.
22 Lee, HC, Jenner, AM, Low, CS & Lee, YK (2006) Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 157, 876–884.
23 Benzie, IFF & Strain, JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”. The FRAP assay. Anal Biochem 239, 70–76.
24 Olano-Martin, E, Gibson, GR & Rastall, RA (2002) Comparison of the in vitro bifidogenic properties of pectins and pectic-oligosaccharides. J Appl Microb 93, 505–511.
25 Tuohy, MK, Kolida, S, Lustenberger, MA & Gibson, RG (2001) The prebiotic effect of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides – a human volunteer study. Br J Nutr 86, 341–348.
26 Spencer, JPE, Schroeter, H, Rechner, AR & Rice-Evans, C (2001) Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid Redox Signal 3, 1023–1039.
27 Frayn, KN (2003) Digestion and intestinal absorption. In Metabolic Regulation. A Human Perspective, 2nd ed. pp. 59–82 [Frayn, KN, editor]. Oxford, UK: Blackwell Publishing.
28 Manach, C, Scalbert, A, Morand, C, Remesy, C & Jimenez, L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727–747.
29 Gibson, RG (1999) Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 129, 1438–1441.
30 Wilson, M (2005) Short-chain fatty acids. In Microbial Inhabitants of Humans, pp. 388–390 [M Wilson, editor]. Cambridge, UK: Cambridge University Press.
31 Hughes, R, Magee, EAM & Bingham, S (2000) Protein degradation in the large intestine: relevance to colorectal cancer. Curr Issues Intest Microbiol 1, 51–58.
32 Matsui, T, Matsukawa, Y, Sakai, T, Nakamura, K, Aoike, A & Kawai, K (1995) Effect of ammonia on cell-cycle progression of human gastric-cancer cells. Eur J Gastroenterol Hepatol 7, S79–S81.
33 Gibson, SAW, McFarlan, C, Hay, S & Macfarlane, GT (1989) Significance of microflora in proteolysis in the colon. Appl Environ Microb 55, 679–683.
34 Stenutz, R, Weintraub, A & Widmalm, G (2006) The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol Rev 30, 382–403.
35 Li, C, Meng, X, Winnik, B, Lee, MJ, Lu, H, Sheng, S, Buckley, B & Yang, CS (2001) Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem Res Toxicol 14, 702–707.
36 Meselhy, MR, Nakamura, N & Hattori, M (1997) Biotransformation of ( − )-epicatecbin 3-O-gallate by human intestinal bacteria. Chem Pharm Bull (Tokyo) 45, 888–893.
37 Garsetti, M, Pellegrini, N, Baggio, C & Brighenti, F (2000) Antioxidant activity in human faeces. Br J Nutr 84, 705–710.
38 Pearson, DC, Jourd'heuil, D & Meddings, JB (1996) The antioxidant properties of 5-aminosalicylic acid. Free Radic Biol Med 21, 367–373.
39 Reimund, JM, Allison, AC, Muller, CD, Dumont, S, Kenney, JS, Baumann, R, Duclos, B & Poindron, P (1998) Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. Eur J Clin Invest 28, 145–150.